NASDAQ:BHST - Nasdaq - CA09076J2074 - Common Stock - Currency: USD
5.9459
+0.64 (+11.97%)
The current stock price of BHST is 5.9459 USD. In the past month the price increased by 13.26%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
UL | UNILEVER PLC-SPONSORED ADR | 23.29 | 138.82B | ||
HLN | HALEON PLC-ADR | 23.44 | 45.58B | ||
KVUE | KENVUE INC | 20.46 | 44.71B | ||
EL | ESTEE LAUDER COMPANIES-CL A | 30.3 | 25.83B | ||
BRBR | BELLRING BRANDS INC | 35.08 | 9.36B | ||
COTY | COTY INC-CL A | 20.39 | 4.98B | ||
IPAR | INTERPARFUMS INC | 28.81 | 4.30B | ||
ELF | ELF BEAUTY INC | 23.86 | 4.23B | ||
ODD | ODDITY TECH LTD-CL A | 22.92 | 2.51B | ||
EPC | EDGEWELL PERSONAL CARE CO | 10.64 | 1.50B | ||
OLPX | OLAPLEX HOLDINGS INC | 10.92 | 941.35M | ||
HLF | HERBALIFE LTD | 4.24 | 837.56M |
Bioharvest Sciences Inc is a CA-based company operating in Personal Care Products industry. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2015-08-05. BioHarvest Sciences Inc. is a Canada-based biotechnology company. The firm offers Botanical Synthesis, its patented technology process to grow plant-based molecules, without the need to grow the underlying plant. The firm is leveraging its Botanical Synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two major business verticals: as a contract development and production organization (CDMO) on behalf of customers seeking complex molecules, and as a creator of proprietary nutraceutical health and wellness products, which includes dietary supplements. The firm operates through two segments: Nutraceuticals and Pharmaceuticals. The firm offers a polyphenol/antioxidant superfruit product called VINIA, which is a red grape powder that supplies the benefits of red wine consumption but without the sugar, calories and alcohol found in wine.
BIOHARVEST SCIENCES INC
1140 - 625 Howe Street
Vancouver BRITISH COLUMBIA CA
Employees: 0
Company Website: https://bioharvest.com/about/
Investor Relations: http://www.bioharvest.com/investors
Phone: 16046221186
The current stock price of BHST is 5.9459 USD. The price increased by 11.97% in the last trading session.
The exchange symbol of BIOHARVEST SCIENCES INC is BHST and it is listed on the Nasdaq exchange.
BHST stock is listed on the Nasdaq exchange.
8 analysts have analysed BHST and the average price target is 9.3 USD. This implies a price increase of 56.37% is expected in the next year compared to the current price of 5.9459. Check the BIOHARVEST SCIENCES INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
BIOHARVEST SCIENCES INC (BHST) has a market capitalization of 103.04M USD. This makes BHST a Micro Cap stock.
BIOHARVEST SCIENCES INC (BHST) currently has 0 employees.
BIOHARVEST SCIENCES INC (BHST) has a support level at 5.94 and a resistance level at 6.09. Check the full technical report for a detailed analysis of BHST support and resistance levels.
The Revenue of BIOHARVEST SCIENCES INC (BHST) is expected to grow by 161.11% in the next year. Check the estimates tab for more information on the BHST EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
BHST does not pay a dividend.
BIOHARVEST SCIENCES INC (BHST) will report earnings on 2025-04-28.
BIOHARVEST SCIENCES INC (BHST) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.19).
The outstanding short interest for BIOHARVEST SCIENCES INC (BHST) is 0.05% of its float. Check the ownership tab for more information on the BHST short interest.
ChartMill assigns a technical rating of 3 / 10 to BHST.
ChartMill assigns a fundamental rating of 2 / 10 to BHST. Both the profitability and financial health of BHST have multiple concerns.
Over the last trailing twelve months BHST reported a non-GAAP Earnings per Share(EPS) of -1.19. The EPS decreased by -734.86% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -66.58% | ||
ROE | -415.37% | ||
Debt/Equity | 2.58 |
ChartMill assigns a Buy % Consensus number of 83% to BHST. The Buy consensus is the average rating of analysts ratings from 8 analysts.
For the next year, analysts expect an EPS growth of -4% and a revenue growth 161.11% for BHST